AURORA, ON–(Marketwire – Jan 30, 2012) – Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP) (the “Company” or “Helix”) announces that its Annual General Meeting (“AGM” or the “Meeting”), was held today as scheduled. The financial statements of the Company were placed before the AGM and the auditors, KPMG LLP Chartered Accountants, were reappointed.